The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective

by Brandon M. Meyers, Arndt Vogel, Paul Marotta, Petr Kavan, Laveena Kamboj, Janice Pan, Marc Geadah, David Trueman, Suthakar Sabapathy
Published 2021-01-01